Fuzzing the brain: Automated stress testing for the safety of ML-driven neurostimulation
This addresses safety concerns for patients using neuroprosthetic devices, offering an incremental but systematic approach to empirical safety assessment.
The paper tackles safety risks in ML-driven neurostimulation devices by adapting coverage-guided fuzzing to detect unsafe stimulation patterns that violate biophysical limits, revealing diverse violations in retinal and cortical encoders with metrics enabling interpretable comparisons.
Objective: Machine learning (ML) models are increasingly used to generate electrical stimulation patterns in neuroprosthetic devices such as visual prostheses. While these models promise precise and personalized control, they also introduce new safety risks when model outputs are delivered directly to neural tissue. We propose a systematic, quantitative approach to detect and characterize unsafe stimulation patterns in ML-driven neurostimulation systems. Approach: We adapt an automated software testing technique known as coverage-guided fuzzing to the domain of neural stimulation. Here, fuzzing performs stress testing by perturbing model inputs and tracking whether resulting stimulation violates biophysical limits on charge density, instantaneous current, or electrode co-activation. The framework treats encoders as black boxes and steers exploration with coverage metrics that quantify how broadly test cases span the space of possible outputs and violation types. Main results: Applied to deep stimulus encoders for the retina and cortex, the method systematically reveals diverse stimulation regimes that exceed established safety limits. Two violation-output coverage metrics identify the highest number and diversity of unsafe outputs, enabling interpretable comparisons across architectures and training strategies. Significance: Violation-focused fuzzing reframes safety assessment as an empirical, reproducible process. By transforming safety from a training heuristic into a measurable property of the deployed model, it establishes a foundation for evidence-based benchmarking, regulatory readiness, and ethical assurance in next-generation neural interfaces.